ADVANCELL’s Dermosome Technology® provides topical administration of lipophilic compounds.
This technology is made up of an oily core that is covered by a polysaccharide layer and other components of the formulation.
Dermosome Technology adheres to the skin, allowing for a longer time of contact. Together with its sub-micrometric size, this increases the surface area of contact between the active molecule and the upper layers of the skin.
With conventional topical delivery methods, molecules with a molecular weight of more than 800 daltons are not able to penetrate or accumulate in the skin. However, ADVANCELL has been able to achieve the topical delivery of compounds with a molecular weight of more than 1,200 daltons.
The company is currently exploring opportunities to commercially exploit this technology.